Opti Active D & K2 has been formulated to be included in therapeutic treatment plans to promote optimal endogenous levels of vitamin D and vitamin K2 in the body, while maximising patient compliance with 1 capsule per day dosage.
Unique formula that combines clinically effective doses of calcifediol with vitamin K2 (menaquinone-7) (MenaQ7®) in a flaxseed oil base.
Calcifediol has 3x per mcg superior bioavailability to colecalciferol.
Vitamin K2 as menaquinone-7 has been found to be better utilised and more effective in supporting both bone and blood vessel heath than supplemental vitamin K1.
Opti Active D & K2 contains 10 micrograms of the active form of vitamin D, calcifediol monohydrate, for superior bioavailability, along with bioactive MK-7. The combination of calcifediol and K2 creates an optimal formula for bone health and strength, as well as supporting bone mineralisation.
Opti Active D & K2 plays a key role in the development and maintenance of healthy bones. Vitamin D helps calcium absorption, and a diet deficient in calcium can lead to osteoporosis in later life. This formula also helps support artery health and muscle function.
Always read the label. Follow the directions for use.
Adults:
1 softgel per day or as directed by a health care practitioner.
Active Ingredients
| Each Softgel Contains: | |
| Calcifediol monohydrate | 10 micrograms |
| Menaquinione-7 (vitamin K2)(MenaQ7®) | 180 micrograms |
Recommended Use:
Calcifediol may have similar effects to Vitamin D. Consult your health care professional before taking in combination with other medicines. This medicine should not be taken in combination with supplements containing Vitamin D without medical advice.
Vitamins and minerals can only be of assistance if dietary intake is inadequate.
Use in children under 9 years is not recommended.
Precautions and Contraindications
Vitamin D supplements should be used with caution in patients with hypercalcaemia, hyperparathyroidism, impaired renal function and sarcoidosis unless under medical supervision.
Vitamin K may antagonise and reverse the therapeutic anticoagulant effects of warfarin. The combination should be avoided, unless under medical supervision.
Adverse effects
Calcifediol and vitamin K are generally well-tolerated at normal therapeutic doses.
Pregnancy and Lactation
Vitamin D and vitamin K are considered safe for use in pregnancy and lactation at normal therapeutic doses.
The RDI dose of vitamin D in pregnancy and lactation is 5 mcg daily (200 IU), with an upper level of intake defined as 80 mcg (3200 IU).
The AI dose of vitamin K in pregnancy and lactation is 60 mcg daily. There is no defined upper level of intake.
This product is indicated for use in adults. Use in children is not recommended.
Opti Active D & K2 has been formulated to be included in therapeutic treatment plans to promote optimal endogenous levels of vitamin D and vitamin K2 in the body, while maximising patient compliance with 1 capsule per day dosage.
Unique formula that combines clinically effective doses of calcifediol with vitamin K2 (menaquinone-7) (MenaQ7®) in a flaxseed oil base.
Calcifediol has 3x per mcg superior bioavailability to colecalciferol.
Vitamin K2 as menaquinone-7 has been found to be better utilised and more effective in supporting both bone and blood vessel heath than supplemental vitamin K1.
Opti Active D & K2 contains 10 micrograms of the active form of vitamin D, calcifediol monohydrate, for superior bioavailability, along with bioactive MK-7. The combination of calcifediol and K2 creates an optimal formula for bone health and strength, as well as supporting bone mineralisation.
Opti Active D & K2 plays a key role in the development and maintenance of healthy bones. Vitamin D helps calcium absorption, and a diet deficient in calcium can lead to osteoporosis in later life. This formula also helps support artery health and muscle function.
Always read the label. Follow the directions for use.
Adults:
1 softgel per day or as directed by a health care practitioner.
Active Ingredients
| Each Softgel Contains: | |
| Calcifediol monohydrate | 10 micrograms |
| Menaquinione-7 (vitamin K2)(MenaQ7®) | 180 micrograms |
Recommended Use:
Calcifediol may have similar effects to Vitamin D. Consult your health care professional before taking in combination with other medicines. This medicine should not be taken in combination with supplements containing Vitamin D without medical advice.
Vitamins and minerals can only be of assistance if dietary intake is inadequate.
Use in children under 9 years is not recommended.
Precautions and Contraindications
Vitamin D supplements should be used with caution in patients with hypercalcaemia, hyperparathyroidism, impaired renal function and sarcoidosis unless under medical supervision.
Vitamin K may antagonise and reverse the therapeutic anticoagulant effects of warfarin. The combination should be avoided, unless under medical supervision.
Adverse effects
Calcifediol and vitamin K are generally well-tolerated at normal therapeutic doses.
Pregnancy and Lactation
Vitamin D and vitamin K are considered safe for use in pregnancy and lactation at normal therapeutic doses.
The RDI dose of vitamin D in pregnancy and lactation is 5 mcg daily (200 IU), with an upper level of intake defined as 80 mcg (3200 IU).
The AI dose of vitamin K in pregnancy and lactation is 60 mcg daily. There is no defined upper level of intake.
This product is indicated for use in adults. Use in children is not recommended.